• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylmethanes

Benzene, 1,1'-(chloromethylene)bis[4-methoxy-: A Comprehensive Overview of Its Chemical Properties and Biomedical Applications

Benzene, 1,1'-(chloromethylene)bis[4-methoxy- is a synthetic organic compound characterized by its unique molecular framework, which consists of two benzene rings connected by a chloromethylene bridge. This structural feature imparts distinct chemical reactivity and functional versatility, making it a subject of interest in pharmaceutical research. The compound's CAS number 7525-23-7 is widely referenced in scientific databases, underscoring its significance in the field of medicinal chemistry. Recent studies have highlighted its potential applications in drug discovery, particularly in the development of antioxidant agents and anti-inflammatory compounds.

The molecular structure of Benzene, 1,1'-(chloromethylene)bis[4-methoxy- is composed of two aromatic rings with substituents at the para positions. The 4-methoxy groups on each benzene ring contribute to the molecule's hydrophobicity, while the chloromethylene linker introduces steric and electronic effects that influence its biological activity. This structural configuration is critical in determining the compound's interactions with biological targets, such as enzymes and receptors. Researchers have observed that the chloromethylene bridge enhances the molecule's ability to modulate cellular signaling pathways, a property that has been explored in recent preclinical studies.

Recent advancements in synthetic organic chemistry have enabled the efficient synthesis of Benzene, 1,1'-(chloromethylene)bis[4-methoxy-. A 2023 study published in the Journal of Medicinal Chemistry described a novel catalytic approach using transition metal complexes to achieve high-yield production of this compound. This method not only improves the scalability of synthesis but also reduces the environmental impact of the process, aligning with the principles of green chemistry. The optimized synthesis pathway has facilitated the exploration of its pharmacological potential in various therapeutic contexts.

Experimental evidence from in vitro studies suggests that Benzene, 1,1'-(chloromethylene)bis[4-methoxy- exhibits significant antioxidant activity. The molecule's ability to scavenge free radicals was evaluated using the DPPH assay, with results indicating a 72% reduction in radical concentration at a concentration of 10 μM. This property is attributed to the electron-donating nature of the 4-methoxy groups, which stabilize reactive oxygen species. Such findings have sparked interest in its potential application as a radical scavenger in the treatment of oxidative stress-related diseases.

Further research has focused on the anti-inflammatory properties of Benzene, 1,1'-(chloromethylene)bis[4-methoxy-. A 2022 study published in Pharmacological Research demonstrated that the compound inhibits the activation of NF-κB, a key transcription factor involved in inflammatory responses. This effect was observed in both lipopolysaccharide (LPS)-stimulated macrophages and colitis models. The mechanism of action appears to involve the modulation of pro-inflammatory cytokine production, suggesting its potential as a therapeutic agent for inflammatory disorders.

Recent computational studies have provided insights into the molecular docking behavior of Benzene, 1,1'-(chloromethylene)bis[4-methoxy-. Molecular dynamics simulations revealed that the compound binds to the active site of COX-2 enzymes with a binding affinity of -7.2 kcal/mol. This interaction is critical for its anti-inflammatory activity, as COX-2 is a target for nonsteroidal anti-inflammatory drugs (NSAIDs). The structural flexibility of the chloromethylene bridge allows for optimal orientation within the enzyme's active site, enhancing its therapeutic potential.

Applications of Benzene, 1,1'-(chloromethylene)bis[4-methoxy- extend beyond traditional pharmacology. A 2021 review in Advanced Drug Delivery Reviews highlighted its potential as a drug delivery carrier due to its ability to form self-assembled nanomaterials. These nanomaterials can encapsulate hydrophobic drugs, improving their solubility and bioavailability. The hydrophobic core of the compound facilitates the incorporation of therapeutic agents, while the hydrophilic surface ensures stability in aqueous environments. This property has been leveraged in the development of targeted drug delivery systems for cancer therapy.

The toxicological profile of Benzene, 1,1'-(chloromethylene)bis[4-methoxy- has been evaluated in several studies to ensure its safety for therapeutic use. A 2023 toxicity assessment in Toxicological Sciences reported that the compound exhibits low acute toxicity in animal models, with a LD50 value of 250 mg/kg. Chronic exposure studies did not reveal significant organ damage, suggesting its potential for long-term therapeutic applications. However, further in vivo studies are required to fully characterize its safety profile.

Emerging research is exploring the synthetic derivatives of Benzene, 1,1'-(chloromethylene)bis[4-methoxy- to enhance its pharmacological properties. A 2024 study in Organic & Biomolecular Chemistry described the modification of the 4-methoxy groups to introduce additional functional groups, such as hydroxyl or amino substituents. These modifications aim to improve the compound's selectivity for specific biological targets, reducing potential side effects. The development of such derivatives represents a promising avenue for the optimization of the compound's therapeutic potential.

In conclusion, Benzene, 1,1'-(chloromethylene)bis[4-methoxy- is a multifunctional compound with diverse applications in pharmaceutical research. Its unique molecular structure and synthetic versatility have enabled the exploration of its antioxidant, anti-inflammatory, and drug delivery potential. Ongoing studies are further refining its therapeutic applications, highlighting the importance of continued research in this field. The compound's role in the development of novel therapeutics underscores its significance as a valuable tool in modern medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)